Type I interferon inhibits interleukin-1 production and inflammasome activation G Guarda, M Braun, F Staehli, A Tardivel, C Mattmann, I Förster, M Farlik, ... Immunity 34 (2), 213-223, 2011 | 1051 | 2011 |
T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes G Guarda, C Dostert, F Staehli, K Cabalzar, R Castillo, A Tardivel, ... Nature 460 (7252), 269-273, 2009 | 292 | 2009 |
NLRC5 deficiency selectively impairs MHC class I-dependent lymphocyte killing by cytotoxic T cells F Staehli, K Ludigs, LX Heinz, Q Seguin-Estevez, I Ferrero, M Braun, ... The Journal of Immunology 188 (8), 3820-3828, 2012 | 176 | 2012 |
NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions K Ludigs, C Jandus, DT Utzschneider, F Staehli, S Bessoles, AT Dang, ... Nature communications 7 (1), 10554, 2016 | 48 | 2016 |
The death domain-containing protein Unc5CL is a novel MyD88-independent activator of the pro-inflammatory IRAK signaling cascade LX Heinz, M Rebsamen, DC Rossi, F Staehli, K Schroder, M Quadroni, ... Cell Death & Differentiation 19 (4), 722-731, 2012 | 33 | 2012 |
NLRC5 deficiency impairs MHC class I-dependent lymphocyte killing by cytotoxic T cells G Guarda, F Staehli, K Ludigs, L Heinz, Q Seguin-Estevez, I Ferrero, ... Immunology 137 (Suppl. 1), 17-17, 2012 | | 2012 |
Immune regulation and function of the NOD-like receptors NLRC5 and NLRP3 F Staehli Université de Lausanne, Faculté de biologie et médecine, 2011 | | 2011 |